Jan Gerstoft

Jan Gerstoft

Auto-generated profile, based on publicly available information

Jan Gerstoft

Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Acta Dermato-Venereologica
Verified
Journal Article
Open access
KSK Salado-Rasmussen
K Salado-Rasmussen
SCS Cowan
S Cowan
JGJ Gerstoft
J Gerstoft
HLH Larsen
H Larsen
SHS Hoffmann
S Hoffmann
JJJ Jensen
J Jensen
The aim of this nationwide study is to determine the strain type diversity among patients diagnosed with syphilis by PCR during a 4-year per...

10 July 2013 in Scandinavian Journal of Immunology
Verified
Journal Article
Open access
PDF file
HHH. J. Hartling
H. J. Hartling
JGJ. C. Gaardbo
J. C. Gaardbo
ARA. Ronit
A. Ronit
MSM. Salem
M. Salem
MLM. Laye
M. Laye
SNSusanne Dam Nielsen
Susanne Dam Nielsen
AlteredTcell homeostasis in chronic hepatitisCvirus (HCV) infection has been demonstrated. However, it is unknown whether fibrosis is associated with more perturbedTcell homeostasis in chronicHCVinfection. The aim of this study was to examine and compareTcell subsets including recent thymic emigrants (RTE), naive, memory, senescent, apoptotic andIL‐7 receptor α (CD127) expressingCD4+andCD8+Tcells as well as telomere length and interferon‐γ production inHCV‐infected patients with (n = 25) and without (n = 26) fibrosis as well as in healthy controls (n = 24). Decreased proportions ofCD4+andCD8+RTEwere found inHCV‐infected patients, especially inHCV‐infected patients with fibrosis (14.3% (9.7–23.0) and 28.8% (16.1–40.5), respectively) compared with healthy controls (24.2% (16.3–32.1),P = 0.004 and 39.1% (31.6–55.0),P = 0.010, respectively). Furthermore,HCV‐infected patients with fibrosis presented with a higher proportion ofCD4+Tcells expressingCD127 compared withHCV‐infected patients without fibrosis [88.4% (84.5–91.0) versus 83.8% (79.9–86.8),P = 0.016]. Thus, impaired thymic output inHCVinfection was found, and high proportion ofCD127+Tcells may illustrate a compensatory mechanism to preserveTcell counts.

19 June 2014 in AIDS
Verified
Journal Article
Open access
RLRebecca Legarth
Rebecca Legarth
LOLars Haukali Omland
Lars Haukali Omland
GKGitte Kronborg
Gitte Kronborg
CLCarsten Schade Larsen
Carsten Schade Larsen
CPCourt Pedersen
Court Pedersen
NONiels Obel
Niels Obel
Objective: To estimate annual employment rates and disability retirement rates (DRRs) among HIV-infected individuals and population controls during the period 1996–2011. Design: A population-based cohort study including all HIV-infected individuals born in Denmark and not reporting intravenous (i.v.) drug abuse as a route of HIV infection or diagnosed with hepatitis C infection (n = 2799) and 22 369 individually matched persons from the background population. Study inclusion was 1 January 1996 or HIV diagnosis, which ever came last. Methods: Data on employment status and disability pension were extracted from Danish national registries. Employment rate and DRR were estimated in each calendar year after study inclusion for the cohorts included before 1996 (pre-1996), 1996–1999 and 2000–2011. Results: Employment rate in the year of study inclusion increased from 54.8% [95% confidence interval (CI) 50.5–59.6] in the pre-1996 cohort to 74.6% (66.9–83.2) and 77.4% (72.8–82.2) in the 1996–1999 and 2000–2011 cohorts, respectively, compared with 85.9–87.2% in the comparison cohorts. Five years from study inclusion, employment rates were 56.1 (51.4–61.1), 66.2 (58.7–74.6) and 70.9% (65.0–77.3) in the pre-1996, 1996–1999 and 2000–2011 cohorts, respectively, compared with 82.5–85.6% in the comparison cohorts. Five years from study inclusion, DRRs were 32.3 (28.9–36.3) in the pre-1996 cohort and decreased to 17.8 (14.1–22.4) and 11.6% (9.4–14.4) in the 1996–1999 and 2000–2011 cohorts, respectively, compared with 5.1–7.2% in the comparison cohorts. Conclusion: After the introduction of HAART, employment rates have increased profoundly among HIV-infected individuals, but have remained lower than in the background population. During the same period, DRRs decreased among HIV-infected individuals, but still remained higher than in the background population.

4 June 2012 in Scandinavian Journal of Immunology
Verified
Journal Article
Open access
PDF file
HHH. J. Hartling
H. J. Hartling
JGJ. C. Gaardbo
J. C. Gaardbo
ARA. Ronit
A. Ronit
LKL. S. Knudsen
L. S. Knudsen
HUH. Ullum
H. Ullum
SNSusanne Dam Nielsen
Susanne Dam Nielsen
The aim of this study was to examine regulatory T cells (Tregs) in peripheral blood and liver tissue in patients with chronic hepatitis C virus (HCV) mono-infection and in patients with HIV/HCV co-infection. In a cross-sectional study were included 51 patients with chronic HCV infection, 24 patients with HIV/HCV co-infection and 24 healthy individuals. CD4+ and CD8+ Tregs were determined using flow cytometry. Fibrosis was examined by transient elastography. Inflammation, fibrosis and Tregs were determined in liver biopsies from 12 patients. Increased frequency of CD4+ and CD8+ Tregs was found in HIV/HCV co-infected patients [median: 6.4% (IQR: 5.7–6.9) and 1.0% (0.7–1.2), respectively] compared to HCV mono-infected patients [5.6% (4.2–6.3), P = 0.01 and 0.5% (0.3–0.7), P < 0.001, respectively]. Furthermore, HCV mono-infected patients had increased frequencies of Tregs compared with healthy controls (P < 0.05). However, no associations between the frequency of Tregs and fibrosis were found. Furthermore, characterization of CD4+ Tregs using CD45RA demonstrated a higher frequency of activated Tregs in both HCV mono-infected and HIV/HCV co-infected patients compared with healthy controls. Finally, number of intrahepatic Tregs was associated with both peripheral CD8+ Tregs and intrahepatic inflammation. In conclusion, HCV mono-infected patients and particularly HIV/HCV co-infected patients have increased the frequency of CD4+ and CD8+ Tregs compared with healthy controls. Furthermore, CD4+ Tregs in infected patients displayed an active phenotype. Tregs were not associated with fibrosis, but a positive correlation between intrahepatic Tregs and inflammation was found. Taken together, these results suggest a role for Tregs in the pathogenesis of chronic HCV infection.

4 August 2015 in Immunity & Ageing
Verified
Journal Article
Open access
PDF file
ALAnne Langkilde
Anne Langkilde
JPJanne Petersen
Janne Petersen
JHJens Henrik Henriksen
Jens Henrik Henriksen
FJFrank Krieger Jensen
Frank Krieger Jensen
JGJan Gerstoft
Jan Gerstoft
OAOve Andersen
Ove Andersen
HIV-infected patients could exhibit accelerated ageing, since age-associated complications like sarcopenia; increased inflammation; lipodystrophy with loss of subcutaneous adipose tissue and/or gain of visceral adipose tissue (VAT); and cardiovascular disease occur at an earlier age. Inflammation is involved in age-associated complications. However, it is not understood whether it is the same inflammatory changes that are involved in the various ageing-associated complications. Our objective was to study whether leptin, interleukin 6 (IL-6), and soluble urokinase plasminogen activator receptor (suPAR) were associated distinctively with adiposity, lipodystrophy and sarcopenia, in HIV-infected patients and healthy Controls. Systemic leptin levels were significantly higher in patients with lipodystrophy than without, whereas there was no difference in IL-6 or suPAR levels. Leptin was significantly positively associated with fat mass index (FMI) and abdominal VAT, but not with lean mass index (LMI). IL-6 was significantly associated with both FMI and VAT, and low LMI. High suPAR was associated with low LMI, and weakly with high FMI and VAT. Leptin reflected adiposity- and lipodystrophy-related inflammation, but not sarcopenia. IL-6 reflected both adiposity-, but also sarcopenia-related inflammation; and suPAR was a marker of sarcopenia-related inflammation. Our results indicate that different inflammatory processes can be active simultaneously contributing to the systemic low grade inflammatory state. Identifying major contributors to circulating leptin, IL-6, and suPAR levels could levels could therefore improve our understanding of which inflammatory processes are involved in the various age-related complications.

15 May 2014 in AIDS
Verified
Journal Article
Open access
AKAndreas Knudsen
Andreas Knudsen
TKTerese Lea Katzenstein
Terese Lea Katzenstein
TBThomas Benfield
Thomas Benfield
NJNiklas Rye Jørgensen
Niklas Rye Jørgensen
GKGitte Kronborg
Gitte Kronborg
ALAnne-Mette Lebech
Anne-Mette Lebech
Biomarkers of endothelial dysfunction, inflammation and coagulation are associated with atherosclerosis and cardiovascular disease, but their association and possible predictive value remain controversial among HIV-1-infected individuals. We sought to investigate the association of seven biomarkers with first-time myocardial infarction (MI) in an HIV-1-infected population. A matched case-control study of 54 cases and 54 controls. We compared 54 HIV-1-infected patients with verified first-time MI and 54 HIV-1-infected controls matched for age, duration of antiretroviral therapy, sex, smoking and no known cardiovascular disease. Levels of high-sensitivity C-reactive protein, soluble endothelial selectin, soluble vascular cell adhesion molecule, soluble intercellular adhesion molecule, matrix metalloprotease 9, myeloperoxidase, and plasminogen activator inhibitor 1 (PAI-1) were measured using a Luminex assay in plasma samples from routine visits both 12 and 2 months prior to the case patient's MI. The two groups had similar HIV characteristics and traditional cardiovascular risk factors. In univariate analysis, PAI-1 levels were associated with MI, whereas none of the other markers showed any association.In multivariate analyses adjusting for the D:A:D risk score, HIV viral load and high-sensitivity C-reactive protein, PAI-1 levels in the highest quartile were associated with a six to seven-fold increased risk of MI in both samples. High levels of PAI-1 were associated with risk of first-time MI in HIV-1-infected individuals independently of cardiovascular risk factors, HIV parameters and antiretroviral therapy. Therefore PAI-1 may be used for risk stratification and prediction of CHD, but further studies are needed.